T-cell replete cord transplants give superior outcomes in high-risk and relapsed/refractory pediatric myeloid malignancy

Claire Horgan, Khushnuma Mullanfiroze,Archana Rauthan,Katharine Patrick,Naeem Akram Butt,Oana Mirci-Danicar,Olya O’Connor,Caroline Furness,Akshay Deshpande,Sarah Lawson,Valerie Broderick,Pamela Evans,Brenda Gibson,Wing Roberts,Salah Ali,Sevasti Galani,Amy A. Kirkwood,Jelena Jovanovic,Richard Dillon,Paul Virgo

Blood advances（2023）

引用 7|浏览21

暂无评分

摘要

•Compared with other cell sources, TRCB transplant results in improved disease-free survival and relapse risk in pediatric AML/MDS.•Compared with other cell sources, cord-transplant cures with less chronic GvHD and particularly improves GvHD-free, relapse-free survival.

查看译文

关键词

replete cord transplants,t-cell,high-risk

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要